Visit the home page
Liberpro Advantage Market Milestones
Technology Advantage Market

 

DNA Therapeutics


 

 

HKIB-GreenPak GMP Biomanufacturing Centre


The Hong Kong Institute of Biotechnology (HKIB):

  • Subsidiary of the Chinese University of HK
  • Local biotechnology landmark infrastructure to foster the development of biotechnology and Traditional Chinese Medicine
  • Three GMP plants (TCM, blood products and biopharmaceuticals)

DNA-based biopharmaceuticals:

  • LiberPro ?a Porcine Growth-Hormone Releasing Factor (pGRF) plasmid

Modern pilot scale facility, with fermentor sizes from 2 to 500 litres